Overview
You can count on TMG as your partner to support the successful outcome of your clinical trials. Our purpose is to surpass your expectations of time, quality and results, and to deliver a higher standard of excellence and integrity in all that we do.
Time
It’s about time you were provided with an organisation and a process customized to meet your every need from rapid site identification and initiation to timely recruitment of patients. TMG is ready to meet your study needs when you are – today.
- Quick feasibility assessment and feedback
- Rapid site identification and recommendation
- Prompt, ‘right first time’ document completion – centrally coordinated
- Quick contract negotiation and completion – one contract, one budget
- Central ethics
- Timely patient recruitment, enrolment and retention
Quality
It’s all about the data. Delivering quality data while protecting the rights and safety of study subjects is our focus every step of the way. We ensure this with our rigorous training and quality support program.
- Investigators and coordinators trained on:
- ICH GCP
- Part C, Division 5
- TMG SOPs
- IATA Dangerous Goods Regulations
- Training aids including self-study modules, newsletters and GCP quizzes
- TMG SOPs supplemented with site-specific SOPs
- GCP support, including:
- Quality checks at TMG sites
- Consultation on interpretation of GCP and regulations
- Assistance with CAPA implementation
- Preparations for regulatory inspections
- Sponsorship of CCRP/CCRC professional accreditation
Results
Our results say it all: our sites routinely surpass enrolment expectations and we perform exceptionally well in key trial metrics including screen-failure rates and subject completion rates. We have built our reputation on our results and our clients choose us again and again.
- Routinely surpass enrolment targets
- Minimized screen-failure rates
- Excellent patient compliance and retention
- Central enrolment strategies and initiatives
- Centralized and site-specific advertising and media creation, placement and metrics
- Experienced in hundreds of Phase II-IV trials in multiple therapeutic areas